Skip to main content
Clinical Trials/DRKS00014687
DRKS00014687
Completed
Phase 4

on-Invasive Electrocardiographic Imaging of Atrial Fibrosis Substrate in Patients with persistent Atrial Fibrillation - AF-SUBSTRAT-MAP-study

niversitäts-Herzzentrum Freiburg-Bad Krozingen - Klinik für Kardiologie und Angiologie II0 sites41 target enrollmentOctober 22, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
I48
Sponsor
niversitäts-Herzzentrum Freiburg-Bad Krozingen - Klinik für Kardiologie und Angiologie II
Enrollment
41
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2018
End Date
August 3, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitäts-Herzzentrum Freiburg-Bad Krozingen - Klinik für Kardiologie und Angiologie II

Eligibility Criteria

Inclusion Criteria

  • Patients age more or equal to 18 years for both sexes
  • \- First catheter ablation procedure for symptomatic persistent AF
  • \- Given and signed consent by the patient to participate to this study

Exclusion Criteria

  • \- Paroxysmal or long persistent AF
  • \- Pregnancy
  • \- Specific exclusion criteria for MRI (Patients with following criteria will not undergo MRI, but can be included in the study for ECG\-Imaging and catheter mapping of atrial Low Voltage Areas): Implanted Cardiac Devices (Pacemaker, ICD), Claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials